Ontology highlight
ABSTRACT: Background
Polypharmacy, or the use of 5 or more daily medications, is common in adults with multiple sclerosis (MS), and is often due to various physical, cognitive, and emotional symptoms. However, research regarding the association between polypharmacy and cognitive outcomes in MS is sparse. Furthermore, individuals with MS often use medications with anticholinergic properties, which are commonly associated with cognitive impairment and other central nervous system adverse effects. Currently, the utility of scales measuring anticholinergic burden in MS is unknown. This study aims to investigate the relationship between polypharmacy, anticholinergic burden, and objective cognitive performance in MS.Methods
We recruited 90 individuals with MS during routine visits at an MS
SUBMITTER: Huebner J
PROVIDER: S-EPMC10930810 | biostudies-literature | 2024 Mar-Apr
REPOSITORIES: biostudies-literature